Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. (SHA:600436)
China flag China · Delayed Price · Currency is CNY
116.60
-0.71 (-0.61%)
Sep 16, 2026, 3:00 PM CST

SHA:600436 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
1,8092,1592,9772,7972,4722,432
Depreciation & Amortization
107.89120.5994.6102.3880.36133.49
Other Amortization
7.688.519.9126.3115.3415.96
Loss (Gain) From Sale of Assets
-0.37-3.41-4.66-1.5-11.48-28.91
Asset Writedown & Restructuring Costs
-0.2-0.390.790.541.82.34
Loss (Gain) From Sale of Investments
-378.36-343.76-136.79-134.51-75.19-23.35
Provision & Write-off of Bad Debts
29.4628.952.9412.27-6.787.1
Other Operating Activities
8.9819.4460.289.36123.88100.42
Change in Accounts Receivable
-132.29-50.42272.9-181.924,258-2,089
Change in Inventory
-241.12-1,721-1,600-758.78-199.39-261.56
Change in Accounts Payable
40.31-222.55-363.45306.43205.02232.58
Operating Cash Flow
1,32677.031,3142,2076,873462.27
Operating Cash Flow Growth
1.40%-94.14%-40.47%-67.89%1386.79%-68.49%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-566.07-339.8-1,068-141.87-175.37-92.17
Sale of Property, Plant & Equipment
0.423.444.131.2513.745.31
Investment in Securities
1,6002,0472,354-2,658-6,170143.32
Other Investing Activities
26.7427.1234.5224.1227.0321.82
Investing Cash Flow
1,0611,7381,324-2,774-6,30578.29

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-5.014.9--1,410
Long-Term Debt Issued
-910.341,1611,1981,593-
Total Debt Issued
883.69915.351,1661,1981,5931,410
Short-Term Debt Repaid
------1,356
Long-Term Debt Repaid
--1,018-1,272-1,180-1,429-31.79
Lease Payments
-44.89-46.51-41.97-38.61-33.17-31.79
Total Debt Repaid
-951.17-1,018-1,272-1,180-1,429-1,387
Net Debt Issued (Repaid)
-67.48-102.31-106.317.85164.1223.09
Common Dividends Paid
-1,965-1,968-2,127-784.64-760.63-569.21
Other Financing Activities
-5.06-4.67-6.98-2.5120.695.9
Financing Cash Flow
-2,037-2,075-2,241-769.3-575.82-540.23

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-9.46-2.268.162.4311.44-4.62
Net Cash Flow
340.85-261.67405.7-1,3343.84-4.29

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
759.96-262.77245.412,0656,698370.11
Free Cash Flow Growth
508.70%--88.11%-69.17%1709.66%-64.69%
Free Cash Flow Margin
9.27%-2.92%2.27%20.53%77.04%4.61%
Free Cash Flow Per Share
1.26-0.440.413.4211.110.61
Levered Free Cash Flow
206.14-848.65-665.121,4111,3701,610
Unlevered Free Cash Flow
224.51-828.81-641.611,4341,3941,631
Free Cash Flow After Leases
715.06-309.28203.452,0266,664338.31

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
691.24771.851,1671,155989.67969.09
Change in Working Capital
-258.34-1,912-1,690-685.584,273-2,177